Found: 19
Select item for more details and to access through your institution.
Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 160, doi. 10.1111/bjh.17080
- By:
- Publication type:
- Article
MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 333, doi. 10.1111/bjh.13298
- By:
- Publication type:
- Article
Histone deacetylase ( HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 559, doi. 10.1111/bjh.12388
- By:
- Publication type:
- Article
Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 6892, doi. 10.3390/jcm11236892
- By:
- Publication type:
- Article
DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 917, doi. 10.3390/cancers11070917
- By:
- Publication type:
- Article
Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 887, doi. 10.3390/cancers11060887
- By:
- Publication type:
- Article
CYT997 Causes apoptosis in human multiple myeloma.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 232, doi. 10.1007/s10637-009-9350-5
- By:
- Publication type:
- Article
Deactylase inhibition in myeloproliferative neoplasms.
- Published in:
- Investigational New Drugs, 2010, v. 28, p. 50, doi. 10.1007/s10637-010-9590-4
- By:
- Publication type:
- Article
Translational Potential of RNA Derived From Extracellular Vesicles in Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.718502
- By:
- Publication type:
- Article
Brick plots: an intuitive platform for visualizing multiparametric immunophenotyped cell clusters.
- Published in:
- BMC Bioinformatics, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12859-020-3469-y
- By:
- Publication type:
- Article
Human myeloma cell‐ and plasma‐derived extracellular vesicles contribute to functional regulation of stromal cells.
- Published in:
- Proteomics, 2021, v. 21, n. 13, p. 1, doi. 10.1002/pmic.202000119
- By:
- Publication type:
- Article
P-055: Extracellular RNA: an emerging biomarker for therapeutic monitoring in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S68, doi. 10.1016/S2152-2650(21)02189-3
- By:
- Publication type:
- Article
Panobinostat (LBH589) in combination with the β-catenin inhibitor Tegavivint (BC2059) exerts significant anti-myeloma activity both in vitro and in vivo.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e137, doi. 10.1016/j.clml.2019.09.227
- By:
- Publication type:
- Article
DNA-repair gene mutations are prevalent in circulating tumour DNA from advanced multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e79, doi. 10.1016/j.clml.2019.09.126
- By:
- Publication type:
- Article
Utilisation of liquid biopsies in functional high-risk myeloma demonstrates a unique mutational pattern and extensive spatial heterogeneity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e7, doi. 10.1016/j.clml.2019.09.010
- By:
- Publication type:
- Article
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00796-9
- By:
- Publication type:
- Article
Changes in immune cell populations following KappaMab, lenalidomide and low‐dose dexamethasone treatment in multiple myeloma.
- Published in:
- Clinical & Translational Immunology, 2023, v. 12, n. 12, p. 1, doi. 10.1002/cti2.1478
- By:
- Publication type:
- Article
The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 12, p. 3464, doi. 10.3390/cells10123464
- By:
- Publication type:
- Article
Heparin-binding epidermal growth factor-like growth factor is expressed in the adhesive lesions of experimental focal glomerular sclerosis.
- Published in:
- Kidney International, 1999, v. 55, n. 6, p. 2310, doi. 10.1046/j.1523-1755.1999.00469.x
- By:
- Publication type:
- Article